Alar Pharmaceuticals Inc. (TPEX:6785)

Alar Pharmaceuticals Statistics

Total Valuation

TPEX:6785 has a market cap or net worth of TWD 11.49 billion. The enterprise value is 9.20 billion.

Market Cap	11.49B
Enterprise Value	9.20B

Important Dates

The next estimated earnings date is Friday, May 8, 2026.

Earnings Date	May 8, 2026
Ex-Dividend Date	Jun 10, 2025

Share Statistics

TPEX:6785 has 66.80 million shares outstanding. The number of shares has increased by 1.11% in one year.

Current Share Class	66.80M
Shares Outstanding	66.80M
Shares Change (YoY)	+1.11%
Shares Change (QoQ)	+0.96%
Owned by Insiders (%)	24.57%
Owned by Institutions (%)	3.03%
Float	37.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4,173.48
PB Ratio	4.78
P/TBV Ratio	4.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-115.42
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-52.89

Financial Position

The company has a current ratio of 31.59, with a Debt / Equity ratio of 0.00.

Current Ratio	31.59
Quick Ratio	30.84
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.02
Interest Coverage	-2,071.58

Financial Efficiency

Return on equity (ROE) is -3.26% and return on invested capital (ROIC) is -170.98%.

Return on Equity (ROE)	-3.26%
Return on Assets (ROA)	-4.16%
Return on Invested Capital (ROIC)	-170.98%
Return on Capital Employed (ROCE)	-6.95%
Weighted Average Cost of Capital (WACC)	4.76%
Revenue Per Employee	101,963
Profits Per Employee	-2.95M
Employee Count	27
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, TPEX:6785 has paid 712,000 in taxes.

Income Tax	712,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.21% in the last 52 weeks. The beta is 0.09, so TPEX:6785's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	+18.21%
50-Day Moving Average	234.16
200-Day Moving Average	220.48
Relative Strength Index (RSI)	36.41
Average Volume (20 Days)	254,269

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6785 had revenue of TWD 2.75 million and -79.68 million in losses. Loss per share was -1.19.

Revenue	2.75M
Gross Profit	2.14M
Operating Income	-167.80M
Pretax Income	-78.97M
Net Income	-79.68M
EBITDA	-162.93M
EBIT	-167.80M
Loss Per Share	-1.19

Balance Sheet

The company has 2.30 billion in cash and 3.57 million in debt, with a net cash position of 2.29 billion or 34.32 per share.

Cash & Cash Equivalents	2.30B
Total Debt	3.57M
Net Cash	2.29B
Net Cash Per Share	34.32
Equity (Book Value)	2.40B
Book Value Per Share	35.63
Working Capital	2.28B

Cash Flow

In the last 12 months, operating cash flow was -171.03 million and capital expenditures -2.87 million, giving a free cash flow of -173.90 million.

Operating Cash Flow	-171.03M
Capital Expenditures	-2.87M
Depreciation & Amortization	4.87M
Net Borrowing	-2.40M
Free Cash Flow	-173.90M
FCF Per Share	-2.60

Margins

Gross Margin	77.73%
Operating Margin	-6,095.10%
Pretax Margin	-2,868.54%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 0.14%.

Dividend Per Share	0.25
Dividend Yield	0.14%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.11%
Shareholder Yield	-0.97%
Earnings Yield	-0.69%
FCF Yield	-1.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6785 has an Altman Z-Score of 88.83 and a Piotroski F-Score of 1.

Altman Z-Score	88.83
Piotroski F-Score	1